Company
Headquarters: Paris, France
Employees: 24
CEO: Mr. Patrick Schiltz
€53.2 Million
EUR as of Jan. 1, 2025
US$55.3 Million
Company | Market Cap (USD) |
---|---|
Intuitive | $216.79 B |
EssilorLuxottica SA | $116.96 B |
Becton, Dickinson and Company | $69.74 B |
HOYA Corp | $45.26 B |
Alcon Inc. | $41.55 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Visiomed Group SA develops and distributes electronic medical devices in Europe and internationally. It provides thermometers, blood pressure monitors, pulse oximeters, connected blood glucometers, and connected electrocardiograms; and pain relief products, such as electrotherapy. The company also offers connected scales and scalable baby scales, as well as prevention and treatment products, such as humidifiers and phototherapies. In addition, it provides hearing products and optics, including presbycusis, as well as family hygiene products. The company offers its products under the ThermoFlash, T. LeClerc, Visiocheck, Innoxa, and BewellConnect brands. Visiomed Group SA was founded in 2007 and is headquartered in Paris, France.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Visiomed Group SA has the following listings and related stock indices.
Stock: Euronext: ALVMG wb_incandescent
Stock: FSX: 7V91 wb_incandescent